Working Towards Equity in Genomic Medicine: A Clinician-Investigator's Perspective - Iftikhar Kullo
November 7, 2022 - Iftikhar J. Kullo, M.D. is a clinician investigator in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota. His research is focused on the genetic basis of atherosclerosis and lipid disorders, as well as the implementation of genomic medicine. Dr. Kullo heads the Atherosclerosis and Lipid Genomics Laboratory, chairs the Cardiovascular Genomics Task Force, and directs the Early Atherosclerosis and Familial Hypercholesterolemia Clinics at the Mayo Clinic. He has been funded by the NIH since 2003 and is currently a principal investigator on two National Human Genome Research Institute programs: the Electronic Medical Records and Genomics (eMERGE) Network and the Polygenic RIsk MEthods in Diverse populations (PRIMED) Consortium. Dr. Kullo also serves on the U.S. National Advisory Council on Human Genome Research.
About the National Human Genome Research Institute (NHGRI) Division of Intramural Research (DIR) Seminar Series: The NHGRI DIR Seminar Series sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
Relevant Links:
NHGRI DIR Seminar Series: https://www.genome.gov/event-calendar...
